Shanghai Industrial Investment Co., a Chinese state-owned conglomerate, plans to launch an RMB50 billion (US$7.28 billion) fund for equity investments in China’s biopharmaceutical sector, said Zhou Jun, CEO and chairman of the company at the ninth State-Owned Assets Summit in Shanghai yesterday.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
